Activation of conventional protein kinase C (PKC) is critical in the generation of human neutrophil extracellular traps

Journal of Inflammation (United Kingdom)

Volumn 10, Issue 1, 2013, Pages

  Gray, Robert D ^a   Lucas, Christopher D ^a   Mackellar, Annie ^a   Li, Feng ^a   Hiersemenzel, Katia ^a   Haslett, Chris ^a   Davidson, Donald J ^a   Rossi, Adriano G ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; GLYCEROL 2 ACETATE 1 OLEATE; ISOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C BETA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RUBOXISTAURIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; NEUTROPHIL; NEUTROPHIL EXTRACELLULAR TRAP; PHARMACOLOGICAL BLOCKING; RESPIRATORY BURST;

EID: 84875158804     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-10-12     Document Type: Article

References (34)

1. Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy. Papayannopoulos V, Staab D, Zychlinsky A, PLoS One 2011 6 28526 10.1371/journal.pone.0028526 22174830
2. Neutrophils and immunity: challenges and opportunities. Nathan C, Nat Rev Immunol 2006 6 173 182 10.1038/nri1785 16498448 (Pubitemid 43290987)
3. Beneficial suicide: why neutrophils die to make NETs. Brinkmann V, Zychlinsky A, Nat Rev Microbiol 2007 5 577 582 10.1038/nrmicro1710 17632569 (Pubitemid 47074113)
4. Neutrophil extracellular traps kill bacteria. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A, Science 2004 303 1532 1535 10.1126/science.1092385 15001782 (Pubitemid 38314426)
5. Novel cell death program leads to neutrophil extracellular traps. Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, Weinrauch Y, Brinkmann V, Zychlinsky A, J Cell Biol 2007 176 231 241 10.1083/jcb.200606027 17210947 (Pubitemid 46143263)
6. Neutrophil extracellular traps: a strategic tactic to defeat pathogens with potential consequences for the host. Medina E, J Innate Immun 2009 1 176 180 10.1159/000203699 20375575
7. Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Hakkim A, Fuchs TA, Martinez NE, Hess S, Prinz H, Zychlinsky A, Waldmann H, Nat Chem Biol 2011 7 75 77 21170021
8. Identification of PKC-isoform-specific biological actions using pharmacological approaches. Way KJ, Chou E, King GL, Trends Pharmacol Sci 2000 21 181 187 10.1016/S0165-6147(00)01468-1 10785652 (Pubitemid 30243200)
9. Protein kinase C intervention: the state of play. Roffey J, Rosse C, Linch M, Hibbert A, McDonald NQ, Parker PJ, Curr Opin Cell Biol 2009 21 268 279 10.1016/j.ceb.2009.01.019 19233632
10. Protein kinase C isoforms in normal and leukemic neutrophils: altered levels in leukemic neutrophils and changes during myeloid maturation in chronic myeloid leukemia. Balasubramanian N, Advani SH, Zingde SM, Leuk Res 2002 26 67 81 10.1016/S0145-2126(01)00098-4 11734305 (Pubitemid 33081092)
11. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, Henson PM, Am J Pathol 1985 119 101 110 2984939 (Pubitemid 15088729)
12. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Rossi AG, Sawatzky DA, Walker A, Ward C, Sheldrake TA, Riley NA, Caldicott A, Martinez-Losa M, Walker TR, Duffin R, Nat Med 2006 12 1056 1064 10.1038/nm1468 16951685 (Pubitemid 44353387)
13. Flavones induce neutrophil apoptosis by down-regulation of Mcl-1 via a proteasomal-dependent pathway. Lucas CD, Allen KC, Dorward DA, Hoodless LJ, Melrose LA, Marwick JA, Tucker CS, Haslett C, Duffin R, Rossi AG, FASEB J 2013 27 3 1084 1094 10.1096/fj.12-218990 23195034
14. Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Metzler KD, Fuchs TA, Nauseef WM, Reumaux D, Roesler J, Schulze I, Wahn V, Papayannopoulos V, Zychlinsky A, Blood 2010 117 953 959 20974672
15. (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e, k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene- 1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta. Jirousek MR, Gillig JR, Gonzalez CM, Heath WF, McDonald JH 3rd, Neel DA, Rito CJ, Singh U, Stramm LE, Melikian-Badalian A, J Med Chem 1996 39 2664 2671 10.1021/jm950588y 8709095 (Pubitemid 26240333)
16. Protein kinase C-beta contributes to NADPH oxidase activation in neutrophils. Dekker LV, Leitges M, Altschuler G, Mistry N, McDermott A, Roes J, Segal AW, Biochem J 2000 347 Pt 1 285 289 10727429 (Pubitemid 30199068)
17. Diphenylene iodonium as an inhibitor of the NADPH oxidase complex of bovine neutrophils. Factors controlling the inhibitory potency of diphenylene iodonium in a cell-free system of oxidase activation. Doussiere J, Vignais PV, Eur J Biochem 1992 208 61 71 10.1111/j.1432-1033.1992.tb17159.x 1324836
18. How neutrophils kill microbes. Segal AW, Annu Rev Immunol 2005 23 197 223 10.1146/annurev.immunol.23.021704.115653 15771570 (Pubitemid 40563169)
19. The neutrophil NADPH oxidase. Babior BM, Lambeth JD, Nauseef W, Arch Biochem Biophys 2002 397 342 344 10.1006/abbi.2001.2642 11795892 (Pubitemid 34852301)
20. Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Yost CC, Cody MJ, Harris ES, Thornton NL, McInturff AM, Martinez ML, Chandler NB, Rodesch CK, Albertine KH, Petti CA, Blood 2009 113 6419 6427 10.1182/blood-2008-07-171629 19221037
21. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Urban CF, Reichard U, Brinkmann V, Zychlinsky A, Cell Microbiol 2006 8 668 676 10.1111/j.1462-5822.2005.00659.x 16548892 (Pubitemid 43372744)
22. Restoration of NET formation by gene therapy in CGD controls aspergillosis. Bianchi M, Hakkim A, Brinkmann V, Siler U, Seger RA, Zychlinsky A, Reichenbach J, Blood 2009 114 2619 2622 10.1182/blood-2009-05-221606 19541821
23. Mouse neutrophil extracellular traps in microbial infections. Ermert D, Urban CF, Laube B, Goosmann C, Zychlinsky A, Brinkmann V, J Innate Immun 2009 1 181 193 10.1159/000205281 20375576
24. NETs: a new strategy for using old weapons. Papayannopoulos V, Zychlinsky A, Trends Immunol 2009 30 513 521 10.1016/j.it.2009.07.011 19699684
25. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, Brinkmann V, Jungblut PR, Zychlinsky A, PLoS Pathog 2009 5 1000639 10.1371/journal.ppat.1000639 19876394
26. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, Meller S, Chamilos G, Sebasigari R, Riccieri V, Sci Transl Med 2011 3 73ra19 10.1126/scitranslmed.3001180 21389263
27. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. Leffler J, Martin M, Gullstrand B, Tyden H, Lood C, Truedsson L, Bengtsson AA, Blom AM, J Immunol 2012 188 7 3522 3531 10.4049/jimmunol.1102404 22345666
28. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, Sci Transl Med 2011 3 73ra20 10.1126/scitranslmed.3001201 21389264
29. Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy. Manzenreiter R, Kienberger F, Marcos V, Schilcher K, Krautgartner WD, Obermayer A, Huml M, Stoiber W, Hector A, Griese M, J Cyst Fibros 2012 11 2 84 92 10.1016/j.jcf.2011.09.008 21996135
30. CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation. Marcos V, Zhou Z, Yildirim AO, Bohla A, Hector A, Vitkov L, Wiedenbauer EM, Krautgartner WD, Stoiber W, Belohradsky BH, Nat Med 2010 16 1018 1023 10.1038/nm.2209 20818377
31. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, Villanueva EC, Shah P, Kaplan MJ, Bruce AT, J Immunol 2011 187 490 500 10.4049/jimmunol.1100123 21606249
32. PKCbeta modulates ischemia-reperfusion injury in the heart. Kong L, Andrassy M, Chang JS, Huang C, Asai T, Szabolcs MJ, Homma S, Liu R, Zou YS, Leitges M, Am J Physiol Heart Circ Physiol 2008 294 1862 H1870 10.1152/ajpheart.01346.2007 18245560 (Pubitemid 351492503)
33. Immunodeficiency in protein kinase cbeta-deficient mice. Leitges M, Schmedt C, Guinamard R, Davoust J, Schaal S, Stabel S, Tarakhovsky A, Science 1996 273 788 791 10.1126/science.273.5276.788 8670417 (Pubitemid 26271522)
34. The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. Skvara H, Dawid M, Kleyn E, Wolff B, Meingassner JG, Knight H, Dumortier T, Kopp T, Fallahi N, Stary G, J Clin Invest 2008 118 3151 3159 10.1172/JCI35636 18688284